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 Abstract 
 Background: Isotope dilution LC-MS/MS methods used in 
the clinical laboratory typically involve multi-point exter-
nal calibration in each analytical series. Our aim was to 
test the hypothesis that determination of target analyte 
concentrations directly derived from the relation of the 
target analyte peak area to the peak area of a correspond-
ing stable isotope labelled internal standard compound 
[direct isotope dilution analysis (DIDA)] may be not infe-
rior to conventional external calibration with respect to 
accuracy and reproducibility. 
 Methods: Quality control samples and human serum 
pools were analysed in a comparative validation protocol 
for cortisol as an exemplary analyte by LC-MS/MS. Accu-
racy and reproducibility were compared between quanti-
fication either involving a six-point external calibration 
function, or a result calculation merely based on peak 
area ratios of unlabelled and labelled analyte. 
 Results: Both quantification approaches resulted in 
similar accuracy and reproducibility. 
 Conclusions: For specified analytes, reliable analyte quan-
tification directly derived from the ratio of peak areas of 
labelled and unlabelled analyte without the need for a time 
consuming multi-point calibration series is possible. This 
DIDA approach is of considerable practical importance 
for the application of LC-MS/MS in the clinical laboratory 
where short turnaround times often have high priority. 
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 Introduction 
 Today liquid chromatography-tandem mass spectrometry 
(LC-MS/MS) methods employed in the clinical labora-
tory are routinely performed as batch analyses, involving 
a multi-level calibrator series followed by  “ unknowns ” . 
This batch mode of analysis is applicable for analytes like 
25-hydroxyvitamin D which do not require reporting within 
short time frames. However, it is likely that LC-MS/MS will 
be increasingly used in fields, such as clinical toxicology 
where often single samples have to be analysed instead of 
batches and it is desirable to obtain results rapidly. This 
may also apply to measuring serum cortisol at a high level 
of accuracy in the context of diagnosing adrenocortical 
dysfunction in septic shock  [1] . Thus, analysing a calibra-
tion series in the conventional and time consuming opera-
tion mode of LC-MS/MS analysis is a substantial drawback 
in clinical mass spectrometry, which indeed makes a more 
widespread application of LC-MS/MS questionable in this 
setting. 
 The current practice to perform multi-point calibra-
tion for clinical LC-MS/MS analyses is adopted, on the 
one hand, from standard biomedical method validation 
protocols and, on the other hand, from traditional, non-
automated ligand binding assays. In these latter tests, 
typi cally complex and non-linear calibration functions 
are observed which definitely require in most cases at least 
five calibration points for the quantification of unknowns. 
In LC-MS/MS, in contrast, in the majority of assays, linear 
response is observed over a wide range of concentrations 
and the need for multi-point calibration is indeed ques-
tionable. Notably, the relation between the number of cal-
ibration samples and the analytical reliability of routine 
LC-MS/MS methods or the  “ stability ” of a calibration is 
hardly studied systematically in the methodological lit-
erature of clinical mass spectrometry so far. 
 Direct isotope dilution analysis (DIDA) is an alter-
native quantification method. The principle of DIDA is 
based on the assumption (and precondition) that the 
Bereitgestellt von | Bayerische Staatsbibliothek
Angemeldet
Heruntergeladen am | 05.11.15 11:26
834      Maier and Vogeser: Direct isotope dilution analysis in clinical MS
physico-chemical behaviour of the native analyte mol-
ecule is very similar to that of its isotope labelled coun-
terpart used as the internal standard. For these labelled 
compounds very similar ionisation yields and conse-
quently LC-MS/MS-peak areas are observed as with native 
(unlabelled) analyte molecules. Therefore, when adding 
the stable isotope labelled internal standard compound 
solution in a strictly quantitative manner to a biologi-
cal sample as the first step of sample preparation, it is 
possible to determine the analyte concentration in the 
sample from the LC-MS/MS-peak area of the native, unla-
belled analyte molecule in relation to the peak area of the 
labelled internal standard compound, by simple calcula-
tion of an individual sample. 
 The aim of our study was to investigate the feasibi-
lity of this DIDA principle in the field of routine clinical 
laboratory application of LC-MS/MS where DIDA is not 
used so far. We tested the hypothesis that applying DIDA 
is not inferior to the standard approach of multi-calibrator 
isotope dilution LC-MS/MS quantification with respect 
to accuracy and reproducibility in the quantification of 
serum cortisol as an exemplary analytical system. 
 Materials and methods 
 A comparative validation protocol was applied including four analy-
tical series: In these series cortisol was determined as described 
previously  [2] in spiked quality control (QC) samples, in human se-
rum pools and in 25 patients ’ samples using LC-MS/MS involving a 
six-point set of calibration samples and three-fold deuterated ([9,12,
12- 2 H]cortisol) as the internal standard in a conventional approach, 
using a standard chromatography soft ware program (MassLynx, 
Waters). Unlabelled cortisol was purchased from Sigma Aldrich 
(Steinheim, Germany; purity 98.7 % ) and labelled cortisol was pur-
chased from Cambridge Isotope Laboratories (Andover, USA; pu-
rity: 98 % ). According to the MS-scan investigation experiments, no 
three-fold deuterated cortisol was detectable in the native cortisol 
formulation, nor was unlabelled cortisol found in the formulation of 
labelled cortisol. Serum pools were prepared from left over samples 
sent for clinical chemistry investigations to our laboratory. Twenty-
fi ve left over individual patients ’ samples sent for cortisol testing to 
our laboratory were included in the series aft er anonymisation. Cali-
brators were prepared by spiking a solution of bovine serum albumin 
(70 g/L) in phosphate buff ered saline to the following cortisol con-
centrations: 12.3, 24.7, 49.4, 98.7, 197 and 395  μ g/L. QC samples were 
prepared in the same way (49.4, 148 and 296  μ g/L). 
 Aft er this conventional analysis and quantifi cation, the peak areas 
(of analyte and labelled internal standard) recorded for QC samples, 
pool samples and patients ’ samples were re-assessed separately for 
each sample. Based on their raw peak areas (Figure  1 )  – as a second 
and independent quantifi cation process  – cortisol concentrations 
were determined using an Excel sheet according to the above de-
scribed DIDA principle, not taking into account the calibration sam-
ples analysed in the respective series at all. In this way for any of the 
four analytical series two sets of quantitative data were obtained for 
each validation material and individual patient ’ s sample (conven-
tional quantifi cation vs. DIDA). Accuracy ( % deviation from target 
concentration for spiked samples) and reproducibility ( % relative 
standard deviation) were comparatively assessed for the two diff er-
ent quantifi cation processes. The FDA criteria for bioanalytical meth-
od validation were applied  [3, 4] . Individual patient ’ s sample results 
were plotted for comparison. 
 Results 
 The data of the validation experiment are summarised in 
Table  1 . For the three spiked QC samples, analytical accu-
racy realised using the DIDA quantification was judged 
to be not inferior when compared to the conventional 
approach of calibration with an external series of cali-
brants. Regarding reproducibility, a total of seven samples 
(spiked QC samples and pool samples) were assessed, and 
in all samples lower CVs were observed for DIDA when 
compared to conventional calibration. Applying a t-test 
for paired observations, CVs of DIDA were significantly 
lower compared to conventional calibration (p < 0.05). 
Very close agreement was found for paired results of 
patients ’ samples (r > 0.999; Figure  2 ). 
 Both methods met the requirements of the FDA 
guidance for bioanalytical method validation (CV and 
bias  < 15 % ; see Table 1)  [3] . 
 Discussion 
 Our study demonstrates that isotope dilution-LC-MS/MS 
can allow  – besides traditional batch analysis  – reliable 
 “ ad-hoc ” analyses of single samples without the need to 
perform a multi-point calibration when the DIDA approach 
is used. In the comparative imprecision study, DIDA even 
showed superior reproducibility when compared to con-
ventional calibration. Potentially multi-point calibration 
introduces a somewhat higher degree of  “ noise ” into the 
analytical system, resulting from the unavoidable varia-
tion in preparing and analysing six individual calibration 
samples. Regarding the degree of analytical accuracy, 
however, both principles were judged equal (Table 1). The 
reliability of DIDA quantification was further confirmed 
by the analysis of a set of individual patients ’ samples, 
displaying fully commutable results. 
 In newborn screening for inborn metabolic diseases 
by LC-MS/MS, the principle of estimating analyte con-
centrations derived from the concentration of the added 
internal standard is already used. This use, however, is in 
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a semi-quantitative approach and in a very high analyte 
concentration range, using flow injection instead of HPLC 
separation  [5] . A similar approach is also described for the 
quantification of inorganic elements  [6] . Here, we dem-
onstrate the applicability of this approach also for the 
quantification of small molecule analytes in a low concen-
tration range and applying chromatographic separation. 
 We demonstrated for one exemplary analyte that DIDA 
is feasible for clinical chemistry application of LC-MS/MS. 
It must be noted, however, that the reliability of DIDA is 
determined by the accuracy of the declared concentra-
tion of the internal standard compound. The content and 
entire isotopic purity of the internal standard preparation 
employed is crucial and should be specified on the level 
of a reference material if DIDA is used in clinical diag-
nostic  – similar to the specification of calibrator samples 
in standard tests of laboratory medicine. Similar to the 
conventional application of stable isotope labelled com-
pounds for internal standardisation, compounds should 
be labelled in at least three positions of the molecule in 
order to avoid spectral overlap with naturally occurring 
molecules. Furthermore, labelling has to be chemically 
stable under storage and mass spectrometric conditions 
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 Figure 1   Example for the quantification of a target analyte  concentration based on the LC-MS/MS peak area of a stable isotope labelled 
internal standard compound. 
 Peak area of the target analyte cortisol, 32,885 counts, and of the internal standard [ 2 H 
3
 ]cortisol, 43,042 counts. Since the ionisation behaviour 
of both cortisol molecules is assumed to be very similar and since the volume of the serum aliquot and the internal standard solution applied 
during sample preparation are identical, the concentration of native cortisol is calculated as follows: Concentration of cortisol  = area of cortisol 
* (concentration of [ 2 H 
3
 ]cortisol/area of [ 2 H 
3
 ]cortisol). For the serum sample with the shown LC-MS/MS chromatogram, a cortisol concentration 
of 150  μ g/L is calculated (concentration of [ 2 H 
3
 ]cortisol in the internal standard solution, 196  μ g/L; 98 % isotopic purity). 
Target concentration,  μ g/L Mean concentration,  μ g/L Accuracy,  % Imprecision, CV % 
CC DIDA CC DIDA CC DIDA
QC 1 49.4 50.4 50.3 102 102 3.9 3.6
QC 2 148 145 149 98.0 101 5.7 2.8
QC 3 296 284 293 95.9 99.0 4.7 1.8
Pool 1 28.3 27.3 4.1 2.6
Pool 2 283 292 5.0 2.9
Pool 3 37.9 37.3 4.6 4.5
Pool 4 202 207 6.8 3.1
 Table 1   Quantification of serum cortisol concentrations by isotope dilution LC-MS/MS using conventional six-point calibration 
(conventional calibration, CC) and using direct isotope dilution analysis (DIDA): Results of a validation study including 20-fold 
determination of quality control (QC) samples and human serum pool samples analysed in four independent series over a period of 14 days. 
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 Figure 2   Comparison of serum cortisol results in 25 clinical samples 
obtained applying conventional calibration and DIDA, respectively. 
 DIDA  – by principle  – only can lead to reliable results 
if the ionisation behaviour of target analyte and stable 
isotope-labelled internal standard compound is very 
similar within the relevant concentration range (cor-
responding to linearity in the conventional calibration 
approach). We studied serum cortisol measurement for 
a proof of concept of DIDA-LC-MS/MS, considering the 
relevance of reliable quantification of this marker for 
intensive care medicine  [1] . When considering applying 
this principle for other analytes in different sample matri-
ces, of course a careful analyte-individual validation of 
this approach of quantification is required, in order to 
exclude differential isotope effects and non-linearity in 
the ionisation behaviour or chromatographic characteris-
tics of stable isotope labelled molecules compared to the 
respective unlabelled counterparts  [7, 8] . In this context, 
for DIDA methods the limits of minimum and maximum 
isotope ratios have to be established, thereby describing 
the measuring range. In our present study on cortisol, 
reliable and consistent results were observed for isotope 
ratios (native cortisol/labelled cortisol) from 0.14 to 1.5. 
 The widespread application of LC-MS/MS in clinical 
laboratories offers substantial potential advantages over 
standard technologies, such as photometry and immuno-
assays: flexible and straightforward method development 
for innovative small molecule analytes; highest analytical 
specificity; the potential to record metabolites patterns; no 
interferences from heterophilic antibodies; low running 
costs for analytical consumables instead of antibody-
based reagents; and reliable standardisation and trace-
ability realising assay-independent reference ranges. Thus, 
LC-MS/MS can address many of the unmet needs of clinical 
diagnostics and enables substantial innovation in clinical 
chemistry  [9] . Given the workflow of today ’ s typical clinical 
laboratories, comprehensive realisation of these potentials 
requires the development of fully automated random-
access MS/MS-based analysers offering identical practi-
cability as standard clinical chemistry analysers do  [10] . 
We believe that the implementation of such an instrument 
concept can be facilitated by the DIDA principle. Our results 
also suggest the short-term implementation of convenient 
DIDA functionalities to standard chromatography software. 
Furthermore, the availability of stable isotope labelled 
materials specified on the level of reference materials is 
desirable. 
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